$348 Million is the total value of Integral Health Asset Management, LLC's 70 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 71.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ARNA | Buy | ARENA PHARMACEUTICALS INC | $17,865,000 | +16.4% | 300,000 | +33.3% | 5.14% | +21.6% |
ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $16,264,000 | -0.3% | 255,000 | -1.9% | 4.68% | +4.1% |
SAGE | Buy | SAGE THERAPEUTICS INC | $14,135,000 | +11.1% | 319,000 | +42.4% | 4.06% | +16.0% |
CVS | New | CVS HEALTH CORP | $12,729,000 | – | 150,000 | +100.0% | 3.66% | – |
CYTK | Sell | CYTOKINETICS INC | $11,616,000 | -16.1% | 325,000 | -53.6% | 3.34% | -12.5% |
GMED | Buy | GLOBUS MED INCcl a | $11,493,000 | +14.0% | 150,000 | +15.4% | 3.30% | +19.1% |
PFE | New | PFIZER INC | $10,753,000 | – | 250,000 | +100.0% | 3.09% | – |
BPMC | Sell | BLUEPRINT MEDICINES CORP | $10,075,000 | +14.5% | 98,000 | -2.0% | 2.90% | +19.6% |
MDT | MEDTRONIC PLC | $10,028,000 | +1.0% | 80,000 | 0.0% | 2.88% | +5.4% | |
NVST | Buy | ENVISTA HOLDINGS CORPORATION | $9,616,000 | +23.6% | 230,000 | +27.8% | 2.76% | +29.1% |
ANTM | Sell | ANTHEM INC | $9,320,000 | -51.2% | 25,000 | -50.0% | 2.68% | -49.0% |
HOLX | New | HOLOGIC INC | $8,857,000 | – | 120,000 | +100.0% | 2.55% | – |
ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $8,782,000 | +56.0% | 60,000 | +71.4% | 2.52% | +62.9% |
PKI | Buy | PERKINELMER INC | $8,665,000 | +40.3% | 50,000 | +25.0% | 2.49% | +46.5% |
SGEN | New | SEAGEN INC | $6,792,000 | – | 40,000 | +100.0% | 1.95% | – |
NTLA | Buy | INTELLIA THERAPEUTICS INC | $6,708,000 | +38.1% | 50,000 | +66.7% | 1.93% | +44.2% |
HZNP | New | HORIZON THERAPEUTICS PUB L | $6,572,000 | – | 60,000 | +100.0% | 1.89% | – |
APLS | Buy | APELLIS PHARMACEUTICALS INC | $6,262,000 | +183.1% | 190,000 | +442.9% | 1.80% | +195.6% |
CNC | New | CENTENE CORP DEL | $6,231,000 | – | 100,000 | +100.0% | 1.79% | – |
REGN | Sell | REGENERON PHARMACEUTICALS | $6,052,000 | -41.4% | 10,000 | -45.9% | 1.74% | -38.8% |
ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $5,998,000 | -9.8% | 90,000 | -28.0% | 1.72% | -5.8% |
FATE | Buy | FATE THERAPEUTICS INC | $5,631,000 | -18.9% | 95,000 | +18.8% | 1.62% | -15.3% |
DXCM | New | DEXCOM INC | $5,469,000 | – | 10,000 | +100.0% | 1.57% | – |
CCXI | Buy | CHEMOCENTRYX INC | $5,130,000 | +119.0% | 300,000 | +71.4% | 1.48% | +128.7% |
LFST | New | LIFESTANCE HEALTH GROUP INC | $5,075,000 | – | 350,000 | +100.0% | 1.46% | – |
ABC | Sell | AMERISOURCEBERGEN CORP | $4,778,000 | -40.4% | 40,000 | -42.9% | 1.37% | -37.7% |
ALNY | ALNYLAM PHARMACEUTICALS INC | $4,720,000 | +11.4% | 25,000 | 0.0% | 1.36% | +16.3% | |
AGL | Buy | AGILON HEALTH INC | $4,718,000 | +16.3% | 180,000 | +80.0% | 1.36% | +21.4% |
NTRA | Sell | NATERA INC | $4,458,000 | -28.6% | 40,000 | -27.3% | 1.28% | -25.4% |
RLAY | Buy | RELAY THERAPEUTICS INC | $4,414,000 | +0.5% | 140,000 | +16.7% | 1.27% | +5.0% |
HRTX | Buy | HERON THERAPEUTICS INC | $4,383,000 | +182.4% | 410,000 | +310.0% | 1.26% | +195.1% |
UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $4,151,000 | -56.4% | 30,000 | -53.8% | 1.19% | -54.5% |
ARCT | New | ARCTURUS THERAPEUTICS HLDGS | $4,061,000 | – | 85,000 | +100.0% | 1.17% | – |
FOLD | Sell | AMICUS THERAPEUTICS INC | $4,059,000 | -11.4% | 425,000 | -10.5% | 1.17% | -7.5% |
EW | Sell | EDWARDS LIFESCIENCES CORP | $3,962,000 | -41.1% | 35,000 | -46.2% | 1.14% | -38.5% |
DNLI | Sell | DENALI THERAPEUTICS INC | $3,784,000 | -40.4% | 75,000 | -7.4% | 1.09% | -37.8% |
ABBV | New | ABBVIE INC | $3,775,000 | – | 35,000 | +100.0% | 1.08% | – |
SIBN | Buy | SI-BONE INC | $3,641,000 | +28.6% | 170,000 | +88.9% | 1.05% | +34.2% |
PTCT | Sell | PTC THERAPEUTICS INC | $3,613,000 | -22.4% | 97,100 | -11.8% | 1.04% | -18.9% |
ATRA | New | ATARA BIOTHERAPEUTICS INC | $3,580,000 | – | 200,000 | +100.0% | 1.03% | – |
New | AVALO THERAPEUTICS INC | $3,543,000 | – | 1,625,000 | +100.0% | 1.02% | – | |
MRTX | Sell | MIRATI THERAPEUTICS INC | $3,538,000 | -56.2% | 20,000 | -60.0% | 1.02% | -54.3% |
RETA | Sell | REATA PHARMACEUTICALS INCcl a | $3,521,000 | -40.8% | 35,000 | -16.7% | 1.01% | -38.1% |
NVRO | Sell | NEVRO CORP | $3,491,000 | -44.6% | 30,000 | -21.1% | 1.00% | -42.1% |
MGNX | New | MACROGENICS INC | $3,350,000 | – | 160,000 | +100.0% | 0.96% | – |
ACRS | Buy | ACLARIS THERAPEUTICS INC | $3,330,000 | +8.4% | 185,000 | +5.7% | 0.96% | +13.1% |
AERI | Sell | AERIE PHARMACEUTICALS INC | $2,850,000 | -56.6% | 250,000 | -39.0% | 0.82% | -54.7% |
BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $2,778,000 | – | 20,000 | +100.0% | 0.80% | – |
INSM | New | INSMED INC | $2,754,000 | – | 100,000 | +100.0% | 0.79% | – |
REPL | REPLIMUNE GROUP INC | $2,668,000 | -22.8% | 90,000 | 0.0% | 0.77% | -19.4% | |
INSP | New | INSPIRE MED SYS INC | $2,329,000 | – | 10,000 | +100.0% | 0.67% | – |
RGNX | New | REGENXBIO INC | $2,306,000 | – | 55,000 | +100.0% | 0.66% | – |
ZY | New | ZYMERGEN INC | $2,107,000 | – | 160,000 | +100.0% | 0.61% | – |
LYEL | New | LYELL IMMUNOPHARMA INC | $2,072,000 | – | 140,000 | +100.0% | 0.60% | – |
AKRO | AKERO THERAPEUTICS INC | $1,900,000 | -9.9% | 85,000 | 0.0% | 0.55% | -6.0% | |
IMGN | New | IMMUNOGEN INC | $1,701,000 | – | 300,000 | +100.0% | 0.49% | – |
LXRX | New | LEXICON PHARMACEUTICALS INC | $1,684,000 | – | 350,000 | +100.0% | 0.48% | – |
MYOV | Sell | MYOVANT SCIENCES LTD | $1,459,000 | -24.6% | 65,000 | -23.5% | 0.42% | -21.4% |
ZYME | New | ZYMEWORKS INC | $1,452,000 | – | 50,000 | +100.0% | 0.42% | – |
DTIL | Sell | PRECISION BIOSCIENCES INC | $1,443,000 | -34.1% | 125,000 | -28.6% | 0.42% | -31.2% |
RVNC | New | REVANCE THERAPEUTICS INC | $1,393,000 | – | 50,000 | +100.0% | 0.40% | – |
BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $1,391,000 | -33.3% | 18,000 | -28.0% | 0.40% | -30.3% |
FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $1,391,000 | +24.2% | 60,000 | +33.3% | 0.40% | +29.9% |
KURA | Sell | KURA ONCOLOGY INC | $1,124,000 | -23.0% | 60,000 | -14.3% | 0.32% | -19.7% |
AVIR | New | ATEA PHARMACEUTICALS INC | $1,052,000 | – | 30,000 | +100.0% | 0.30% | – |
AGIO | Sell | AGIOS PHARMACEUTICALS INC | $923,000 | -44.2% | 20,000 | -33.3% | 0.26% | -41.8% |
MGTA | Buy | MAGENTA THERAPEUTICS INC | $655,000 | -10.8% | 90,000 | +20.0% | 0.19% | -6.9% |
PTGX | New | PROTAGONIST THERAPEUTICS INC | $620,000 | – | 35,000 | +100.0% | 0.18% | – |
CMRX | Buy | CHIMERIX INC | $557,000 | -7.2% | 90,000 | +20.0% | 0.16% | -3.0% |
LBPH | LONGBOARD PHARMACEUTICALS IN | $266,000 | -2.9% | 30,000 | 0.0% | 0.08% | +1.3% | |
ARDX | Exit | ARDELYX INC | $0 | – | -70,000 | -100.0% | -0.15% | – |
ALEC | Exit | ALECTOR INC | $0 | – | -35,000 | -100.0% | -0.20% | – |
KDMN | Exit | KADMON HLDGS INC | $0 | – | -225,000 | -100.0% | -0.24% | – |
MSON | Exit | MISONIX INC | $0 | – | -45,000 | -100.0% | -0.28% | – |
Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.40% | – | |
AXGN | Exit | AXOGEN INC | $0 | – | -70,000 | -100.0% | -0.42% | – |
KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.43% | – |
ALT | Exit | ALTIMMUNE INC | $0 | – | -160,000 | -100.0% | -0.43% | – |
ONEM | Exit | 1LIFE HEALTHCARE INC | $0 | – | -50,000 | -100.0% | -0.46% | – |
MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -0.49% | – |
BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -125,000 | -100.0% | -0.54% | – |
UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -5,000 | -100.0% | -0.55% | – |
CERC | Exit | CERECOR INC | $0 | – | -675,000 | -100.0% | -0.61% | – |
AXNX | Exit | AXONICS INC | $0 | – | -40,000 | -100.0% | -0.70% | – |
IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -50,000 | -100.0% | -0.91% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -150,000 | -100.0% | -1.01% | – |
PNTG | Exit | PENNANT GROUP INC | $0 | – | -90,000 | -100.0% | -1.01% | – |
BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -17,000 | -100.0% | -1.05% | – |
DHR | Exit | DANAHER CORPORATION | $0 | – | -15,000 | -100.0% | -1.11% | – |
ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -25,000 | -100.0% | -1.22% | – |
ACCD | Exit | ACCOLADE INC | $0 | – | -100,000 | -100.0% | -1.50% | – |
A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -40,000 | -100.0% | -1.63% | – |
TFX | Exit | TELEFLEX INCORPORATED | $0 | – | -20,000 | -100.0% | -2.21% | – |
LHCG | Exit | LHC GROUP INC | $0 | – | -42,000 | -100.0% | -2.32% | – |
SNY | Exit | SANOFIsponsored adr | $0 | – | -175,000 | -100.0% | -2.54% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -35,000 | -100.0% | -3.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
REVVITY INC | 13 | Q3 2023 | 4.2% |
BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-09 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-03 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-02 |
13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.